|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 300.56 USD | +2.09% |
|
+1.81% | -14.82% |
| 06-30 | United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says | MT |
| 06-30 | UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating | MT |
Transcripts
Search
04-30 | ||
03-11 | ||
03-03 | ||
02-26 | ||
01-13 | ||
11-12 | ||
30/10/24 | ||
05/09/24 | ||
04/09/24 | ||
31/07/24 | ||
12/06/24 | ||
01/05/24 | ||
12/03/24 | ||
05/03/24 | ||
21/02/24 | ||
08/01/24 | ||
08/11/23 | ||
01/11/23 | ||
11/09/23 | ||
02/08/23 | ||
03/05/23 | ||
13/03/23 | ||
07/03/23 | ||
22/02/23 | ||
09/01/23 |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition